Contents of this document
- Following an organizational change, the former Asia Pacific segment is now presented separately as Asia and Oceania
- EBITDA¥1,200 millionYear on year against the same period last year+5.8%
- EBITDA margin13.3 %
- Total sales volume in the Japan business206.6 million casesYear on year against the same period last year+2.0%
- Suntory Natural Water sales volume63.8 million casesYear on year against the same period last year+2.0%
- BOSS sales volume47 million casesYear on year against the same period last year+2.0%
- Iyemon sales volume26.5 million casesYear on year against the same period last year+2.0%
- GREEN DA・KA・RA sales volume18.5 million casesYear on year against the same period last year-5.0%
- Total sales volume of Foods for Specified Health Uses and Foods with Function Claims20.6 million casesYear on year against the same period last year+6.0%
- Oasis (France) sales volume172 million LYear on year against the same period last year+3.0%
- Schweppes (France) sales volume94 million LYear on year against the same period last year+5.0%
- Orangina (France) sales volume82 million LYear on year against the same period last year-4.0%
- Lucozade (United Kingdom and Ireland) sales volume234 million LYear on year against the same period last year+2.0%
- Ribena (United Kingdom and Ireland) sales volume41 million LYear on year against the same period last year-4.0%
- Schweppes (Spain and Portugal) sales volume56 million LYear on year against the same period last year-1.0%
| Item | Details |
|---|---|
| Document type | Supplementary materials to the earnings report |
| Fiscal Period Covered | Second quarter (interim period) of the fiscal year ending December 2026 |
| Net Sales | ¥8,999 million (YoY +11.6%) |
| Operating profit | ¥740 million (YoY +3.0%) |
| Ordinary income | ¥733 million (YoY +4.5%) |
| Net income | ¥421 100 million (interim profit attributable to owners of the parent) (YoY +2.3%) |
| Gross Profit Margin | 37 % |
| Operating profit margin | 8.2 % |
| Selling, general and administrative expenses | ¥2,564 million |
| Segment results | Revenue Japan ¥3,601 million (YoY +4.6%) / Europe ¥2,119 million (YoY +12.0%) / Asia ¥1,696 million (YoY +12.9%) / Oceania ¥600 million (YoY +69.7%) / Americas ¥982 million (YoY +12.5%) / Segment profit Japan ¥213 million (YoY +16.8%) / Europe ¥303 million (YoY -6.6%) / Asia ¥199 million (YoY -0.8%) / Oceania ¥52 million (YoY +156.2%) / Americas ¥103 million (YoY +0.1%) / EBITDA Japan ¥376 million (YoY +8.8%) / Europe ¥406 million (YoY +1.3%) / Asia ¥294 million (YoY +8.6%) / Oceania ¥95 million (YoY +32.0%) / Americas ¥139 million (YoY -0.2%) |
| Breakdown of Factors Affecting the Change | Segment profit of the Japan business 2025 interim-period segment profit 183 / Sales volume impact 38 / Activity and mix impact 93 / Change in raw material prices and logistics costs -102 / Change in sales promotion and advertising expenses 0 / Other 2 / 2026 interim-period segment profit 213 |
| Key KPIs | Indicator name EBITDA / Value ¥1,200 million / Year on year against the same period last year ¥5.8 million, Indicator name EBITDA margin / Value 13.3 % / Year on year against the same period last year Not disclosed, Indicator name Total sales volume in the Japan business / Value 206.6 million cases / Year on year against the same period last year 2 million cases, Indicator name Suntory Natural Water sales volume / Value 63.8 million cases / Year on year against the same period last year 2 million cases, Indicator name BOSS sales volume / Value 47 million cases / Year on year against the same period last year 2 million cases, Indicator name Iyemon sales volume / Value 26.5 million cases / Year on year against the same period last year 2 million cases, Indicator name GREEN DA・KA・RA sales volume / Value 18.5 million cases / Year on year against the same period last year -5 million cases, Indicator name Total sales volume of Foods for Specified Health Uses and Foods with Function Claims / Value 20.6 million cases / Year on year against the same period last year 6 million cases, Indicator name Oasis (France) sales volume / Value 172 million L / Year on year against the same period last year 3 million L, Indicator name Schweppes (France) sales volume / Value 94 million L / Year on year against the same period last year 5 million L, Indicator name Orangina (France) sales volume / Value 82 million L / Year on year against the same period last year -4 million L, Indicator name Lucozade (United Kingdom and Ireland) sales volume / Value 234 million L / Year on year against the same period last year 2 million L, Indicator name Ribena (United Kingdom and Ireland) sales volume / Value 41 million L / Year on year against the same period last year -4 million L, Indicator name Schweppes (Spain and Portugal) sales volume / Value 56 million L / Year on year against the same period last year -1 million L |
| Financial targets | Debt-to-equity ratio End of fiscal 2025 -0.05 times / End of 2026 interim period -0.06 times |
| Capital expenditures | ¥349 100 million (capital expenditures) |
| New initiatives | Following an organizational change, the former Asia Pacific segment is now presented separately as Asia and Oceania |
Items this document does not state (16)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.In the Japan business, higher sales volumes and activity and mix effects boosted profit, while higher raw material prices and logistics costs reduced profit. Revenue in the overseas businesses includes the impact of foreign exchange, and Asia and Oceania have been presented as separate segments following an organizational change.